Dermatology
Dermatology
Advertisement
Leah LawrenceDermatology | June 4, 2025
AI model uses smartphone images to objectively track eczema severity.
Nsisong Asanga, PhDDermatology | May 29, 2025
Phase 3 trial shows ivarmacitinib is effective and safe for moderate to severe atopic dermatitis in teens and adults.
Jordana JampelASCO 2025 | May 28, 2025
Researchers identified the pathologic and clinical characteristics of patients who experience disease relapse.
Izzah NawazDermatology | May 27, 2025
Study finds early lebrikizumab response in AD linked to lower inflammation—may guide personalized treatment plans.
Jordana JampelDermatology | May 23, 2025
Treatment with the drug demonstrated lesion and pain control in moderate to severe disease.
Jordana JampelDermatology | May 22, 2025
Symptomatic benefits of treatment on the severity of pustules, erythema, and scaling were observed.
Leah LawrenceDermatology | May 20, 2025
TLR9 gene variants may influence vitiligo risk, new research suggests innate immunity plays a key role.
Leah LawrenceDermatology | May 20, 2025
Elevated bilirubin levels may lower vitiligo risk, suggesting a protective role, new genetic study finds.
Leah LawrenceDermatology | May 20, 2025
Tofacitinib shows promising 6-month results for alopecia totalis and universalis, with notable hair regrowth and safety profi
Leah LawrenceDermatology | May 20, 2025
Topical JAK inhibitors show promise for vitiligo, but current evidence lacks strong statistical support, study finds.
Joy ManningDermatology | May 15, 2025
PEPITEM and its analogues show promise as steroid-free anti-inflammatory agents in psoriasis and immune cell regulation.
Jordana JampelDermatology | May 7, 2025
Individuals with TSW had elevated levels of a form of vitamin B3, causing inflammation separate from eczema symptoms.
Jordana JampelDermatology | May 7, 2025
Topical application of PEPITEM addressed systemic inflammation, suggesting therapeutic benefit beyond the skin.
Jordana JampelDermatology | May 5, 2025
The researchers focused on microbial changes that occur from childhood to adulthood and stability of existing microbiomes.
Joy ManningDermatology | May 1, 2025
A new pattern of nonscarring alopecia, termed macular alopecia, may represent an underrecognized clinical entity.
Jordana JampelDermatology | April 29, 2025
The correlation between stigma and chronic skin disease negatively affects childrens' mental health according to the study.
Jordana JampelDermatology | April 2, 2025
Relative rates of serious infection were calculated using medication use time versus time not used.
Advertisement